The FDA has accepted a supplemental Biologics License Application for moving up the use of Abecma, a CAR-T cell therapy, for adult patients with multiple myeloma.
Alex Biese
Advertisement
A nationally-published, award-winning journalist, Alex Biese joined the CURE team as an assistant managing editor in April 2023. Prior to that, Alex's work was published in outlets including the Chicago Sun-Times, MTV.com, USA TODAY and the Press of Atlantic City. Alex is a member of NLGJA: The Association of LGBTQ+ Journalists, and also performs at the Jersey Shore with the acoustic jam band Somewhat Relative.
Articles by Alex Biese
Acupuncture improved the sleep of cancer survivors faced with chronic pain, opening the door to nonpharmacological methods of sustainable pain management, according to a recent study.
Social media, including Facebook groups, can help connect patients with rare cancers like granulosa cell tumors to researchers, allowing them to learn more about disease management.
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Navigating Life’s Path With Multiple Myeloma
2
What the Art of Kintsugi Can Teach During a Cancer Journey
3
FDA Fast Tracks NG-350A for Some With Advanced Rectal Cancer
4
Questions of Faith and Spirituality Matter for Patients with Gynecologic Cancers
5
